Evidence map›Paper›PMID 36242841›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2022

Deep sequencing analysis of clinical samples from patients with acute infectious conjunctivitis during the COVID-19 delta surge in Madurai, India.

Prajna Lalitha, N Venkatesh Prajna, Rameshkumar Gunasekaran, Gonugunta Vishnu Teja, Sankalp S Sharma, Armin Hinterwirth, Kevin Ruder, Lina Zhong, Cindi Chen, Michael Deiner and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Coxsackievirus A24 causing acute conjunctivitis in a 2023 outbreak in Vietnam.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Viruses Associated with Acute Conjunctivitis in Vanuatu.The American journal of tropical medicine and hygiene · 2023
    Article
  10. Outpatient human coronavirus associated conjunctivitis in India.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Prajna LalithaAravind Eye Hospital, Madurai, India.
N Venkatesh PrajnaAravind Eye Hospital, Madurai, India.
Rameshkumar GunasekaranAravind Eye Hospital, Madurai, India.
Gonugunta Vishnu TejaAravind Eye Hospital, Madurai, India.
Sankalp S SharmaAravind Eye Hospital, Madurai, India.
Armin HinterwirthFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, United States.
Kevin RuderFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, United States.
Lina ZhongFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, United States.
Cindi ChenFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, United States.
Michael DeinerDepartment of Ophthalmology, University of California, San Francisco, CA, United States.
ChunHong HuangDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, United States.
Benjamin A PinskyDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, United States; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Thomas M LietmanFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, United States; Department of Ophthalmology, University of California, San Francisco, CA, United States.
Thuy DoanFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, United States; Department of Ophthalmology, University of California, San Francisco, CA, United States. Electronic address: thuy.doan@ucsf.edu.
Gerami D SeitzmanFrancis I. Proctor Foundation, University of California San Francisco, San Francisco, CA, United States; Department of Ophthalmology, University of California, San Francisco, CA, United States.
SCORPIO (Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes) Study Group
Aravind Eye Hospital · INUniversity of California, San Francisco · USSan Francisco Foundation · USStanford University · US

Funding

Seasonal Conjunctivitis Outbreak Reporting for Prevention and Improved Outcomes (SCORPIO)R01EY032041 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DOAN, THUY A · 2021 to 2025
$2.0M
NEI NIH HHS R01 EY032041
6 · The paper itself

Abstract

backgroundSeasonal outbreaks of infectious conjunctivitis remain a public health issue. Determination of outbreak etiologies in the context of a worldwide pandemic may provide useful information to guide public health strategies. The aim of this study was to identify pathogens associated with outpatient infectious conjunctivitis during the COVID-19 Delta surge.

methodsThis prospective study was conducted from April 2021 to September 2021. All outpatients presenting to the Aravind Eye Center (Madurai, India) with signs and symptoms consistent with acute infectious conjunctivitis were eligible. Three swabs were obtained from each participant: one from each conjunctiva and one from the anterior nares. Samples were processed for metagenomic RNA deep sequencing (RNA-seq).

resultsSamples from 106 study participants were sequenced. The most common presenting symptoms were tearing (86%) and itching (71%). Preauricular lymphadenopathy was present in 38% of participants. 20% of participants had close contacts with similar symptoms. Systemic symptoms such as coughing, runny nose, vomiting or diarrhea were uncommonly reported. 60% of all participants used some medicated eye drops upon enrollment. 75% of study participants demonstrated infection with human adenovirus D (HAdV-D). 11% of conjunctivitis was associated with SARS-CoV-2. 15% had no definitive pathogen detected. 8% of all participants had codetection of more than one pathogen on RNA-seq.

conclusionsDuring the COVID-19 Delta surge in India, HAdV-D was the most common pathogen associated with infectious conjunctivitis. SARS-CoV-2 was the second most common associated pathogen. Seasonal surveillance may be necessary for the determination of emerging and reemerging pathogens responsible for infectious conjunctivitis.

Indexed as

Adenoviruses, HumanConjunctivitisCOVID-19Acute DiseaseHigh-Throughput Nucleotide SequencingHumansIndiaProspective StudiesSARS-CoV-2

Identifiers

PMID36242841
PMCPMC9534536
OpenAlexW4302028136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.